Archive: https://archive.today/L3gLc
From the post:
>Precision Neuroscience Corporation (Precision), a leader in brain–computer interface (BCI) technology, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Layer 7 Cortical Interface, its high-resolution cortical electrode array, for use in the recording, monitoring, and stimulation of electrical activity on the surface of the brain. The array is a core component of Precision’s fully implantable, wireless brain–computer interface system, which is currently in development. With this clearance, the Layer 7 Cortical Interface is now authorized for commercial use with implantation durations of up to 30 days.
Archive: https://archive.today/L3gLc
From the post:
>>Precision Neuroscience Corporation (Precision), a leader in brain–computer interface (BCI) technology, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Layer 7 Cortical Interface, its high-resolution cortical electrode array, for use in the recording, monitoring, and stimulation of electrical activity on the surface of the brain. The array is a core component of Precision’s fully implantable, wireless brain–computer interface system, which is currently in development. With this clearance, the Layer 7 Cortical Interface is now authorized for commercial use with implantation durations of up to 30 days.